

Ep 83: A New Cancer Breakthrough with Ivan Dimov of Orca Bio
Apr 5, 2024
Ivan Dimov of Orca Bio discusses their groundbreaking cell therapy alternative for leukemia, with virtually zero rejection, potentially curing other diseases. Their journey to FDA approval includes challenges in collaboration, regulation, and insurance, with a unique in-house commercialization approach.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 3min
Bridging Research and Impact: The Journey of Cell Therapies
02:46 • 5min
In-depth Analysis of Orca Bio's Innovative Therapy for Blood Cancer Patients
07:17 • 2min
Revolutionizing Cancer Treatment with Designer Immune System
08:54 • 9min
Innovative Immune System Reboot for Treating Diseases
17:51 • 2min
Revolutionizing Drug Distribution with ORCA's Innovative Approach
19:33 • 13min